Business Segments · Cost of products sold
Cardiovascular — Cost of products sold
Boston Scientific Cardiovascular — Cost of products sold increased by 12.3% to $1.04B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 15.5%, from $904.00M to $1.04B. Over 3 years (FY 2022 to FY 2025), Cardiovascular — Cost of products sold shows an upward trend with a 14.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2022
Last reportedQ4 2025
How to read this metric
Rising costs relative to sales may indicate supply chain inefficiencies or increased manufacturing expenses.
Detailed definition
Includes the direct costs associated with manufacturing and delivering cardiovascular medical devices, such as raw mater...
Peer comparison
Standard 'Cost of Goods Sold' (COGS) metric for manufacturing segments.
Metric ID:
bsx_segment_cardiovascular_cost_of_products_soldHistorical Data
16 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $659.25M | $659.25M | $659.25M | $659.25M | $701.25M | $701.25M | $701.25M | $701.25M | $811.00M | $851.00M | $838.00M | $904.00M | $925.00M | $1.05B | $930.00M | $1.04B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +6.4% | +0.0% | +0.0% | +0.0% | +15.7% | +4.9% | -1.5% | +7.9% | +2.3% | +13.1% | -11.1% | +12.3% |
| YoY Change | — | — | — | — | +6.4% | +6.4% | +6.4% | +6.4% | +15.7% | +21.4% | +19.5% | +28.9% | +14.1% | +22.9% | +11.0% | +15.5% |
Range$659.25M – $1.05B
CAGR+13.0%
Avg YoY Growth+14.5%
Median YoY Growth+14.8%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's cardiovascular — cost of products sold?
- Boston Scientific (BSX) reported cardiovascular — cost of products sold of $1.04B in Q4 2025.
- How has Boston Scientific's cardiovascular — cost of products sold changed year-over-year?
- Boston Scientific's cardiovascular — cost of products sold increased by 15.5% year-over-year, from $904.00M to $1.04B.
- What is the long-term trend for Boston Scientific's cardiovascular — cost of products sold?
- Over 3 years (2022 to 2025), Boston Scientific's cardiovascular — cost of products sold has grown at a 14.4% compound annual growth rate (CAGR), from $2.64B to $3.95B.
- What does cardiovascular — cost of products sold mean?
- The direct costs incurred to produce and sell cardiovascular products.